Susceptibilities of Candida albicans multidrug transporter mutants to various antifungal agents and other metabolic inhibitors

Antimicrobial Agents and Chemotherapy

Volumn 40, Issue 10, 1996, Pages 2300-2305

  Sanglard, Dominique ^a   Ischer, Françoise ^a   Monod, Michel ^a   Bille, Jacques ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

4 NITROQUINOLINE 1 OXIDE; ABC TRANSPORTER; AMOROLFINE; AMPHOTERICIN B; ANTIFUNGAL AGENT; BREFELDIN A; CERULENIN; CRYSTAL VIOLET; CYCLOHEXIMIDE; FLUCONAZOLE; FLUCYTOSINE; FLUPHENAZINE; ITRACONAZOLE; KETOCONAZOLE; NIKKOMYCIN Z; NOCODAZOLE; PRADIMICIN A; PYRROLE DERIVATIVE; TERBINAFINE;

ARTICLE; CANDIDA ALBICANS; CONCENTRATION RESPONSE; DRUG ACCUMULATION; DRUG SENSITIVITY; DRUG TRANSPORT; FUNGUS CULTURE; FUNGUS GROWTH; FUNGUS MUTANT; GENE DELETION; GENE DISRUPTION; GROWTH INHIBITION; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

EID: 0029820482     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.40.10.2300     Document Type: Article

References (31)

1. Balzi, E., and A. Goffeau. 1994. Genetics and biochemistry of yeast multidrug resistance. Biochim. Biophys. Acta 1187:152-162.
2. Bissinger, P. H., and K, Kuchler. 1994. Molecular cloning and expression of the Saccharomyces cerevisiae STS1 gene product. A yeast ABC transporter conferring mycotoxin resistance. J. Biol. Chem. 269:4180-4186.
3. Clark, F. S., T. Parkinson, C. A. Hitchcock, and N. Gow. 1996. Correlation between rhodamine 123 accumulation and azole sensitivity in Candida species: possible role for drug efflux in drug resistance. Antimicrob. Agents Chemother. 40:419-425.
4. Decottignies, A., L. Lambert, P. Catty, H. Degand, E. A. Epping, R. W. Moye, E. Balzi, and A. Goffeau. 1995. Identification and characterization of SNQ2, a new multidrug ATP binding cassette transporter of the yeast plasma membrane. J. Biol. Chem. 270:18150-18157.
5. Egner, R., Y. Mahe, R. Pandjaitan, V. Huter, A. Lamprecht, and K. Kuchler. 1995. ABC-transporters in yeast: from mating to multidrug resistance, p. 57-96. In S. S. Rothman (ed.), Membrane protein transport, vol. 2. JAI Press, Greenwich, Conn.
6. Ehrenhofer, M. A., F. E. Wurgler, and C. Sengstag. 1994. The Saccharomyces cerevisiae SGE1 gene product: a novel drug-resistance protein within the major facilitator superfamily. Mol. Gen. Genet. 244:287-294.
7. Evans, G. L., B. F. Ni, C. A. Hrycyna, D. Chen, S. V. Ambudkar, I. Pastan, U. A. Germann, and M. M. Gottesman. 1995. Heterologous expression systems for P-glycoprotein: E. coli, yeast, and baculovirus. J. Bioenerg. Biomembr. 27:43-52.
8. Fling, M. E., J. Kopf, A. Tamarkin, J. A. German, H. A. Smith, and Y. Koltin. 1991. Analysis of a Candida albicans gene that encodes a novel mechanism for resistance to benomyl and methotrexate. Mol. Gen. Genet. 227:318-329.
9. Fonzi, W. A., and M. Y. Irwin. 1992. Isogenic strain construction and gene mapping in Candida albicans. Genetics 134:717-728.
10. Funs-Tomc, J. C., B. Minassian, E. Huczko, B. Kolek, D. P. Bonner, and R. E. Kessler. 1995. In vitro antifungal and fungicidal spectra of a new pradimicin derivative, BMS-181184. Antimicrob. Agents Chemother. 39: 295-300.
11. Georgopapadakou, N. H., and T. J. Walsh. 1994. Human mycoses - drugs and targets for emerging pathogens. Science 264:371-373.
12. Goldway, M., D. Teff, R. Schmidt, A. B. Oppenheim, and Y. Koltin. 1995. Multidrug resistance in Candida albicans: disruption of the BEN' gene. Antimicrob. Agents Chemother. 39:422-426.
13. Gonzalez, A., A. Jimenez, D. Vasquez, J. E. Davies, and D. Schindler. 1978. Studies on the mode of action of hygromycin B, an inhibitor of translocation in eukaryotes. Biochim. Biophys. Acta 521:459-469.
14. Graham, T. R., P. A. Scott, and S. D. Emr. 1993. Brefeldin A reversibly blocks early but not late protein transport steps in the yeast secretory pathway. EMBO J. 12:869-877.
15. Hait, W. N., J. F. Gesmonde, and J. S. Lazo. 1994. Effect of anti-calmodulin drugs on the growth and sensitivity of C6 rat glioma cells to bleomycin. Anticancer Res. 14:1711-1721.
16. Hanahan, D. 1985. Techniques for transformation of E. coli, p. 109-135. In D. M. Glover (ed.), DNA cloning. A practical approach. IRL Press, Oxford.
17. Johnson, E. M., D. W. Warnock, J. Luker, S. R. Porter, and C. Scully. 1995. Emergence of azole drug resistance in Candida species from HIV-infected patients receiving prolonged fluconazole therapy for oral candidosis. J. Antimicrob. Chemother. 35:103-114.
18. Kerridge, D. 1986. Mode of action of clinically important antifungal drugs. Adv. Microb. Physiol. 27:1-72.
19. Kross, J., W. D. Henner, S. M. Hecht, and W. A. Haseltine. 1982. Specificity of deoxyribonucleic acid cleavage by bleomycin, phlcomycin and tallysomycin. Biochemistry 21:4310-4318.
20. Morisaki, N., H, Funabashi, R. Shimazawa, J. Furukawa, A. Kawaguchi, S. Okuda, and S. Iwasaki. 1993. Effect of side-chain structure on inhibition of yeast fatty-acid synthase by cerulenin analogues. Eur. J. Biochem. 211:111-115.
21. Mutoh, E., M. Mochizuki, A. Ohta, and M. Takagi. 1995. Inducible expression of a gene encoding an L41 ribosomal protein responsible for the cycloheximide-resistant phenotype in the yeast Candida maltosa. J. Bacteriol. 177:5383-5386.
22. Nelissen, B., P. Mordant, J. L. Jonniaux, R. Dewachter, and A. Goffeau. 1995. Phylogenetic classification of the major superfamily of membrane transport facilitators, as deduced from yeast genome sequencing. FEBS Lett. 377:232-236.
23. Odds, F. C., J. Schmid, and D. R. Soll. 1990. Epidemiology of Candida infections in AIDS, p. 67-74. In H. Vanden Bossche et al. (ed.), Mycoses in AIDS patients. Plenum Press, New York.
24. Powderly, W. G. 1994. Resistant candidiasis. AIDS Res. Hum. Retroviruses 10:925-929.
25. Prasad, R., P. Dewergifosse, A. Goffeau, and E. Balzi. 1995. Molecular cloning and characterization of a novel gene of Candida albicans, CDR1, conferring multiple resistance to drugs and antifungals. Curr. Genet. 27:320-329.
26. Rex, J. H., M. G. Rinaldi, and M. A. Pfaller. 1995. Resistance of Candida species to fluconazole. Antimicrob. Agents Chemother. 39:1-8.
27. Sanglard, D., K. Kuchler, F. Ischer, J. L. Pagani, M. Monod, and J. Bille. 1995. Mechanisms of resistance to azoic antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters. Antimicrob. Agents Chemother. 39:2378-2386.
28. Vanden Bossche, H., P. Marichal, and F. C. Odds. 1994. Molecular mechanisms of drug resistance in fungi. Trends Microbiol. 2:393-400.
29. Vuffray, A., C. Durussel, P. Boerlin, F. Boerlin-Petzold, J. Bille, M. P. Glauser, and J. P. Chave. 1994. Oropharyngeal candidiasis resistant to single-dose therapy with fluconazole in HIV-infected patients. AIDS 8:708-709.
30. Yadan, J. C., M. Gonneau, P. Sarthou, and F. Le Goffic. 1984. Sensitivity to nikkomycin Z in Candida albicans: role of peptide permeases. J. Bacteriol. 160:884-888.
31. Yokoyama, K., H. Kaji, K. Nishimura, and M. Miyaji. 1990. The role of microfilaments and microtubules in apical growth and dimorphism of Candida albicans. J. Gen. Microbiol. 136:1067-1075.